We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


AnaSpec Introduces new Collection of Bcl Peptides

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

AnaSpec has introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. These important regulators of apoptosis have been implicated in a number of neoplasms, including melanoma, breast, prostate, and lung carcinomas, as well as schizophrenia and autoimmunity.

The Bcl-2 family is comprised of more than 20 members, divided into 3 subfamilies. Depending on Bcl-2 subcellular localization, it can inhibit (anti-apoptotic members) or induce (pro-apoptotic members) apoptosis.